Literature DB >> 16731861

A hepatocyte nuclear factor-4 alpha gene (HNF4A) P2 promoter haplotype linked with late-onset diabetes: studies of HNF4A variants in the Norwegian MODY registry.

Helge Raeder1, Lise Bjørkhaug, Stefan Johansson, Kjersti Mangseth, Jørn V Sagen, Anne Hunting, Ivar Følling, Odd Johansen, Marit Bjørgaas, Povel N Paus, Oddmund Søvik, Anders Molven, Pål R Njølstad.   

Abstract

Variants in hepatocyte nuclear factor (HNF)-4alpha cause maturity-onset diabetes of the young, type 1 (MODY1) and may also be risk factors for type 2 diabetes. We sequenced the HNF4A gene of 95 MODY3-negative probands from the Norwegian MODY Registry. We found three novel coding variants in exon 8 of HNF4A: G326R, T339I, and W340X. In intron 7, we noted a single nucleotide polymorphism in the binding site of a previously published primer pair, which in some cases caused allelic drop out when amplifying exon 8. We also detected two novel sequence variants of the P2 promoter region, of which P2 -192C>G showed linkage with diabetes in two families (maximal logarithm of odds score of 3.1 and 0.8, respectively). This variant and a surrounding haplotype restricted by 3.7 Mb was also found in two Danish MODY pedigrees. The age of onset was higher in the P2 -192C>G carriers (median 45 years) compared with that reported for other MODY1 individuals. We could not support a biological role of the P2 promoter variant by in vitro transfection assays. In conclusion, we have identified three novel HNF4A mutations and a 3.7-Mb haplotype, including the HNF4A P2 promoter, which was linked with diabetes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16731861     DOI: 10.2337/db05-1677

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  10 in total

1.  Novel mechanisms of regulation of the expression and transcriptional activity of hepatocyte nuclear factor 4α.

Authors:  Shangdong Guo; Hong Lu
Journal:  J Cell Biochem       Date:  2018-09-07       Impact factor: 4.429

2.  Clinical utility gene card for: Maturity-onset diabetes of the young.

Authors:  Kevin Colclough; Cécile Saint-Martin; José Timsit; Sian Ellard; Christine Bellanné-Chantelot
Journal:  Eur J Hum Genet       Date:  2014-02-12       Impact factor: 4.246

3.  Assessing the phenotypic effects in the general population of rare variants in genes for a dominant Mendelian form of diabetes.

Authors:  Jason Flannick; Nicola L Beer; Alexander G Bick; Vineeta Agarwala; Janne Molnes; Namrata Gupta; Noël P Burtt; Jose C Florez; James B Meigs; Herman Taylor; Valeriya Lyssenko; Henrik Irgens; Ervin Fox; Frank Burslem; Stefan Johansson; M Julia Brosnan; Jeff K Trimmer; Christopher Newton-Cheh; Tiinamaija Tuomi; Anders Molven; James G Wilson; Christopher J O'Donnell; Sekar Kathiresan; Joel N Hirschhorn; Pål R Njølstad; Tim Rolph; J G Seidman; Stacey Gabriel; David R Cox; Christine E Seidman; Leif Groop; David Altshuler
Journal:  Nat Genet       Date:  2013-10-06       Impact factor: 38.330

Review 4.  Investigating parent of origin effects in studies of type 2 diabetes and obesity.

Authors:  Evadnie Rampersaud; Braxton D Mitchell; Adam C Naj; Toni I Pollin
Journal:  Curr Diabetes Rev       Date:  2008-11

5.  Examination of Rare Variants in HNF4 α in European Americans with Type 2 Diabetes.

Authors:  Jacklyn N Hellwege; Pamela J Hicks; Nicholette D Palmer; Maggie C Y Ng; Barry I Freedman; Donald W Bowden
Journal:  J Diabetes Metab       Date:  2011-10-20

6.  Disease progression and search for monogenic diabetes among children with new onset type 1 diabetes negative for ICA, GAD- and IA-2 Antibodies.

Authors:  Sven Pörksen; Lene Bjerke Laborie; Lotte Nielsen; Marie Louise Max Andersen; Tone Sandal; Heidi de Wet; Erik Schwarcz; Jan Aman; Peter Swift; Mirjana Kocova; Eugen J Schönle; Carine de Beaufort; Philip Hougaard; Frances Ashcroft; Anders Molven; Mikael Knip; Henrik B Mortensen; Lars Hansen; Pål R Njølstad
Journal:  BMC Endocr Disord       Date:  2010-09-23       Impact factor: 2.763

Review 7.  Monogenic diabetes in children and young adults: Challenges for researcher, clinician and patient.

Authors:  Annabelle S Slingerland
Journal:  Rev Endocr Metab Disord       Date:  2006-09       Impact factor: 6.514

8.  Targeted sequencing identifies novel variants in common and rare MODY genes.

Authors:  Lucas S de Santana; Lilian A Caetano; Aline D Costa-Riquetto; Pedro C Franco; Renata P Dotto; André F Reis; Letícia S Weinert; Sandra P Silveiro; Marcio F Vendramini; Flaviene A do Prado; Giovanna C P Abrahão; Ana Gregória F P de Almeida; Maria da G Rodrigues Tavares; Wagner Rodrigo B Gonçalves; Augusto C Santomauro Junior; Bruno Halpern; Alexander A L Jorge; Marcia Nery; Milena G Teles
Journal:  Mol Genet Genomic Med       Date:  2019-10-08       Impact factor: 2.183

Review 9.  Insights on pathogenesis of type 2 diabetes from MODY genetics.

Authors:  Michael N Weedon; Timothy M Frayling
Journal:  Curr Diab Rep       Date:  2007-04       Impact factor: 5.430

10.  Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young.

Authors:  S Ellard; C Bellanné-Chantelot; A T Hattersley
Journal:  Diabetologia       Date:  2008-02-23       Impact factor: 10.122

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.